Avelas Biosciences
develops luminous cancer map that helps to assist the surgical oncologist during surgery... Read moreAvelas Biosciences
develops luminous cancer map that helps to assist the surgical oncologist during surgery... Read more
News
Oct 18, 2021
GlobalNewswire
Press Release: Avelas Biosciences : Avelas makes senior appointments and provides update on pegloprastide Phase III clinical program
Oct 18, 2021
FinanzNachrichten
Avelas Biosciences: Avelas Biosciences: Avelas makes senior appointments and provides update on pegloprastide Phase III clinical program
Dec 14, 2020
MarketScreener
Avelas Biosciences: Avelas Receives FDA Breakthrough Therapy Designation for Pegloprastide (AVB-620) for Use During Breast Cancer Surgery
Aug 04, 2020
Business Wire
Press Release: Avelas Biosciences : Avelas Announces Top-Line Data Showing Pegloprastide (AVB-620) Can Significantly Improve Cancer Detection in Real Time During Breast Cancer Surgery
Sep 18, 2019
Avelas Biosciences Youtube Channel
Avelas Biosciences posted a video "Avelas Biosciences Overview" on YOUTUBE
Sep 26, 2018
PR Newswire
Press Release: Avelas Biosciences : Avelas Biosciences to Present at 2018 Cantor Global Healthcare Conference
Aug 02, 2018
PR Newswire
Press Release: Avelas Biosciences : Avelas Biosciences Initiates Period 2 of Phase 2 Study of AVB-620 in Women With Primary, Nonrecurrent Breast Cancer Undergoing Surgery
Jun 14, 2018
PR Newswire
Press Release: Avelas Biosciences : Avelas Biosciences to Present at JMP Securities Annual Life Sciences Conference
Mar 21, 2018
PharmiWeb
Avelas Biosciences: Avelas Biosciences to Present at Needham & Company 17th Annual Healthcare Conference
Jan 04, 2018
PR Newswire
Press Release: Avelas Biosciences : Avelas Biosciences Completes Period 1 Patient Enrollment in Phase 2 Study of AVB-620 in Women with Primary, Nonrecurrent Breast Cancer Undergoing Surgery
Avelas Biosciences Competitors
1
2
3
4
5
6
7
8
9
10